These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6355850)

  • 1. Sowing hematopoietic seeds.
    Rappeport JM
    N Engl J Med; 1983 Dec; 309(22):1385-6. PubMed ID: 6355850
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of various conditioning regimens on the outcome of bone marrow transplantation for leukemia.
    Devergie A; Socie G; Esperou-Bourdeau H; Ribaud P; Traineau R; Gluckman E
    Nouv Rev Fr Hematol (1978); 1991; 33(6):437-9. PubMed ID: 1818295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.
    Santos GW; Tutschka PJ; Brookmeyer R; Saral R; Beschorner WE; Bias WB; Braine HG; Burns WH; Elfenbein GJ; Kaizer H
    N Engl J Med; 1983 Dec; 309(22):1347-53. PubMed ID: 6355849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation for leukemia after conditioning with busulfan and cyclophosphamide. Bone marrow morphology in the early recovery phase.
    Cao DC; Tutschka PJ
    Chin Med J (Engl); 1991 Apr; 104(4):267-76. PubMed ID: 2065543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue.
    Lu C; Braine HG; Kaizer H; Saral R; Tutschka PJ; Santos GW
    Cancer Treat Rep; 1984 May; 68(5):711-7. PubMed ID: 6373004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High-dose busulfan, VP-16 and ACNU therapy with stem cell transplantation for the treatment of children with acute leukemia].
    Ikuta K; Fujioka K; Sumita H; Takahashi H; Sekiguchi H; Kai S; Kajigaya Y; Funabiki T; Sakai H; Matsuyama S
    Rinsho Ketsueki; 1993 May; 34(5):636-42. PubMed ID: 8100284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity and non-relapse mortality after allogeneic bone marrow transplantation in adult leukemia patients conditioned with busulfan plus cyclophosphamide: a retrospective comparison of oral versus intravenous busulfan.
    Kim SE; Lee JH; Choi SJ; Lee JH; Ryu SG; Lee KH
    Haematologica; 2005 Feb; 90(2):285-6. PubMed ID: 15710597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation.
    Copelan EA; Penza SL; Elder PJ; Ezzone SA; Scholl MD; Bechtel TP; Belt PS; Avalos BR
    Bone Marrow Transplant; 2000 Jun; 25(12):1219-22. PubMed ID: 10871724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.
    Yeager AM; Kaizer H; Santos GW; Saral R; Colvin OM; Stuart RK; Braine HG; Burke PJ; Ambinder RF; Burns WH
    N Engl J Med; 1986 Jul; 315(3):141-7. PubMed ID: 3523241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation following busulfan and 90 mg/kg of cyclophosphamide.
    Avalos BR; Klein JL; Kapoor N; Copelan EA
    Bone Marrow Transplant; 1993 Dec; 12(6):655-8. PubMed ID: 8136749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of bone marrow transplantation in the treatment of leukemia].
    Ehninger G; Schuler U; Haas R
    Internist (Berl); 1993 Jun; 34(6):550-7. PubMed ID: 8101514
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission.
    Inoue T; Ikeda H; Yamazaki H; Tang JT; Song C; Teshima T; Murayama S; Ohtani M; Shibata H; Masaoka T
    Strahlenther Onkol; 1993 Apr; 169(4):250-5. PubMed ID: 8488461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged remission of accelerated phase Philadelphia chromosome negative chronic myeloid leukemia following autologous recovery of normal hematopoietic elements after busulfan/cyclophosphamide and allogeneic marrow transplantation.
    Kapoor N; Keever CA; Hsu SH; Copelan EA; Tutschka PJ
    Bone Marrow Transplant; 1992 Feb; 9(2):143-5. PubMed ID: 1349249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Busulfan and cyclophosphamide as conditioning regimen for autologous BMT in acute lymphoblastic leukemia.
    Porcellini A; Manna A; Moretti L; Carotenuto M; Greco MM; Bodenizza C
    Bone Marrow Transplant; 1989 May; 4(3):331-3. PubMed ID: 2659120
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of hematopoietic stem cell transplantation in treatment of leukemia].
    Runde V; Schaefer UW
    Internist (Berl); 1996 Oct; 37(10):1030-9. PubMed ID: 9019447
    [No Abstract]   [Full Text] [Related]  

  • 17. [Total body irradiation in hematology: clinical indications and prospects].
    Corvò R
    Recenti Prog Med; 1999 Nov; 90(11):601-4. PubMed ID: 10608150
    [No Abstract]   [Full Text] [Related]  

  • 18. Allogeneic bone marrow transplantation for hematological malignancies following therapy with high doses of busulphan and cyclophosphamide.
    Angelucci E; Polchi P; Lucarelli G; Galimberti M; Baronciani D; Giardini C; Durazzi SM; Moretti L; Donati M
    Haematologica; 1989; 74(5):455-61. PubMed ID: 2511115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting.
    Tutschka PJ
    Bone Marrow Transplant; 1993; 12 Suppl 1():34-6. PubMed ID: 8374557
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.
    Geller RB; Myers S; Devine S; Larson RA; Williams SF; Park CL; O'Toole K; Chandler C; Topper RL
    Bone Marrow Transplant; 1992 Jan; 9(1):41-7. PubMed ID: 1543948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.